Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes (Q41989355)

14 October 2017

Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes (English)

1 reference

14 October 2017

1 reference

Sateeshkumar Sathigari

1

1 reference

14 October 2017

Gurkishan Chadha

2

1 reference

14 October 2017

Y-H Phillip Lee

3

1 reference

14 October 2017

Nydeia Wright

4

1 reference

14 October 2017

Daniel L Parsons

5

1 reference

14 October 2017

Vijay K Rangari

6

1 reference

14 October 2017

Oladiran Fasina

7

1 reference

14 October 2017

R Jayachandra Babu

8

1 reference

14 October 2017

language of work or name

English

0 references

publication date

16 January 2009

1 reference

14 October 2017

1 reference

14 October 2017

10

1 reference

14 October 2017

1

1 reference

14 October 2017

81-87

1 reference

The utility of cyclodextrins for enhancing oral bioavailability

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Cyclodextrins as pharmaceutical solubilizers.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Practical considerations in development of solid dosage forms that contain cyclodextrin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Cyclodextrins in drug delivery: an updated review

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Further studies of the effect of compaction pressure on the dissolution efficiency of direct compression systems.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Molecular properties of WHO essential drugs and provisional biopharmaceutical classification

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Preformulation study of the inclusion complex warfarin-beta-cyclodextrin

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Medium chain triglycerides as vehicle for palatable oral liquids

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Kinetics and mechanism of hydrolysis of efavirenz

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663670

Mechanism of drug dissolution rate enhancement from β-cyclodextrin-drug systems

3 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19148759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19148759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Formulation and food effects on the oral absorption of a poorly water soluble, highly permeable antiretroviral agent

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19148759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1208/S12249-008-9180-3

1 reference

Dimensions Publication ID

14 October 2017

0 references

1 reference

14 October 2017

PubMed publication ID

19148759

1 reference